Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...

Immune evasion in ovarian tumors involves a complex array of immune suppressive factors and cells that effectively halt the generation and clonal expansion of antitumor immunity. Genetic changes ...

University of Galway’s Dr Aideen Ryan is looking at mechanisms in supportive tissue cells with the aim of enhancing the ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

"Or it can be even more complex with say a large network of pathways within the tumor microenvironment all working to suppress the body's immune response," said Chen, who is also a researcher with ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

"Or it can be even more complex with say a large network of pathways within the tumor microenvironment all working to suppress the body's immune response," said Chen, who is also a researcher with ...

CD39-Targeted Therapies Near Key Milestones, First Approval Projected by 2029Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD39 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent ...

which tumors use to create an immune-suppressive environment around themselves. The sEVs also stimulated T cells, giving another boost to anticancer immune activation. Overall, sEVs' apparent ...